SCHEMBL3490153

SCHEMBL3490153

COc1cccc(CN2C(=O)N(Cc3ccccc3)c3cc(Cl)cc(N4CCN(C)CC4)c3S2(=O)=O)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CMA1 P23946 1/20 0.46
GAA P10253 2/20 0.45
SIGMAR1 Q99720 1/20 0.44
CHRM5 P08912 1/20 0.42
ALDH1A1 P00352 6/20 0.42
USP2 O75604 5/20 0.42
CYP3A4 P08684 5/20 0.42
CYP2C19 P33261 2/20 0.42
CASP1 P29466 2/20 0.41
CASP7 P55210 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
CYP1A2 P05177 2/20 0.41
CYP2D6 P10635 2/20 0.41
CYP2C9 P11712 2/20 0.41
HSD17B10 Q99714 1/20 0.41
CLK4 Q9HAZ1 1/20 0.41
GLA P06280 1/20 0.41
HIF1A Q16665 1/20 0.41
HTR1A P08908 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3489300 0.93 MEN1 (0.42) CMA1GAASIGMAR1ALDH1A1MEN1
SCHEMBL3490336 0.91 CMA1 (0.44) CMA1GAASIGMAR1CHRM5ALDH1A1
SCHEMBL3490278 0.91 MAPT (0.48) ALDH1A1KMT2AMAPTKDM4EHPGD
SCHEMBL3490480 0.90 MAPT (0.47) GAASIGMAR1ALDH1A1CYP2C19MEN1
SCHEMBL3489318 0.88 MAPT (0.45) GAAALDH1A1USP2CYP3A4CYP2C19
SCHEMBL3489623 0.88 MAPT (0.46) ALDH1A1MEN1KMT2AMAPTKDM4E
SCHEMBL3490201 0.87 HCRTR1 (0.47) CMA1GAAALDH1A1HTR1AHTR7
SCHEMBL3489163 0.87 MAPT (0.43) GAAMEN1KMT2AHTR1AHTR7
SCHEMBL3490669 0.87 MAPT (0.42) ALDH1A1KMT2AHTR6MAPTKDM4E
SCHEMBL3489063 0.87 MAPT (0.42) ALDH1A1KMT2AHTR1AMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100035866-A1 NOVEL SUBSTITUTED-1, 1-DIOXO-BENZO[1,2,4]THIADIAZIN-3ONES, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2010-02-11 US claimed
US-20100035866-A1 NOVEL SUBSTITUTED-1, 1-DIOXO-BENZO[1,2,4]THIADIAZIN-3ONES, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2010-02-11 US disclosed
US-20100035866-A1 NOVEL SUBSTITUTED-1, 1-DIOXO-BENZO[1,2,4]THIADIAZIN-3ONES, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2010-02-11 US disclosed
US-20100035866-A1 NOVEL SUBSTITUTED-1, 1-DIOXO-BENZO[1,2,4]THIADIAZIN-3ONES, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2010-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100035866-A1 NOVEL SUBSTITUTED-1, 1-DIOXO-BENZO[1,2,4]THIADIAZIN-3ONES, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME OPRD1, HTR6, HTR1D CMA1 917/4885GAA 4362/4885SIGMAR1 25/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.